Van Hulzen Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Sell |
20,890
-2,474
| -11% | -$205K | 0.14% | 113 |
|
|
2025
Q1 | $1.96M | Sell |
23,364
-970
| -4% | -$81.4K | 0.18% | 103 |
|
|
2024
Q4 | $2.24M | Buy |
24,334
+1,576
| +7% | +$145K | 0.16% | 101 |
|
|
2024
Q3 | $2.11M | Buy |
22,758
+8,186
| +56% | +$760K | 0.15% | 109 |
|
|
2024
Q2 | $1.2M | Buy |
14,572
+582
| +4% | +$47.9K | 0.08% | 143 |
|
|
2024
Q1 | $928K | Sell |
13,990
-9,314
| -40% | -$618K | 0.06% | 175 |
|
|
2023
Q4 | $1.32M | Buy |
23,304
+9,992
| +75% | +$567K | 0.09% | 135 |
|
|
2023
Q3 | $725K | Buy |
13,312
+4,259
| +47% | +$232K | 0.06% | 180 |
|
|
2023
Q2 | $609K | Sell |
9,053
-5,569
| -38% | -$375K | 0.05% | 164 |
|
|
2023
Q1 | $753K | Buy |
14,622
+2,452
| +20% | +$126K | 0.07% | 139 |
|
|
2022
Q4 | $560K | Buy |
12,170
+484
| +4% | +$22.3K | 0.06% | 159 |
|
|
2022
Q3 | $592K | Buy |
11,686
+537
| +5% | +$27.2K | 0.07% | 153 |
|
|
2022
Q2 | $508K | Buy |
11,149
+223
| +2% | +$10.2K | 0.06% | 165 |
|
|
2022
Q1 | $508K | Buy |
10,926
+1,525
| +16% | +$70.9K | 0.05% | 169 |
|
|
2021
Q4 | $472K | Buy |
9,401
+1,842
| +24% | +$92.5K | 0.05% | 185 |
|
|
2021
Q3 | $401K | Buy |
7,559
+25
| +0.3% | +$1.33K | 0.06% | 178 |
|
|
2021
Q2 | $460K | Buy |
+7,534
| New | +$460K | 0.07% | 162 |
|